BGI VISTA™ PGS

Introduction

Preimplantation genetic screening (PGS) evaluates embryos for extra or missing chromosomes. PGS is an option for any in vitro fertilization (IVF) patient.

BGI VISTA™ PGS is used in conjunction with an IVF cycle. Embryos remain on-site at the patient’s IVF center. Cells are removed from an embryo and sent to BGI for genetic analysis.

BGI VISTA™ PGS can improve the chance of a successful pregnancy while reducing the chance of miscarriage or of having a child with a chromosome condition.

Who should consider BGI VISTA™ PGS?

Any Individual or couple undergoing IVF, especially those with the following indications:

Advanced maternal age (AMA);
Individuals/couples who have suffered repeated implantation failure (RIF);
Individuals/couples who have suffered repeated miscarriage (RM);
Severe male factor infertility;
Individuals/couples who are carriers of chromosomal abnormalities or have given birth to a child with chromosomal abnormalities.

Note: this test is considered a screening test, not a diagnostic test. Before making any treatment decisions, all patients should discuss results with their healthcare provider, who can recommend confirmatory, diagnostic testing where appropriate. This testing service has not been cleared or approved by the US FDA and is not available in the USA.

SAMPLE:

DNA from blastocyst cells (Recommended);
Blastocyst cells (Frozen)
TA TIME

10 working days
TECHNOLOGY:

Low coverage WGS

Why Choose BGI VISTA™ PGS?

Comprehensive – covers all 24 chromosomes and can detect Aneuploidy/Structural Aberrations
Accurate – 99.9% accuracy with NGS
Affordable – one of the lowest price with high qualities in market

Workflow

Ordering BGI VISTA™ PGS is easy.

STEP 1

Physician orders test
STEP 2

Sample collection
STEP 3

WGA & sequencing at BGI
STEP 4

Results sent to physician

Learn more

Test Overview